Michael Thorpy, MD, professor of neurology, Albert Einstein College of Medicine, discusses promising pharmacological ...

FDA advisers have voted against the use of MDMA as a post-traumatic stress disorder (PTSD) treatment; House members have ...

Experts on Alzheimer disease discuss how the introduction of disease-modifying therapies has impacted the treatment landscape ...

The panel provides insights on the economic impact of advanced approaches for diagnosing Alzheimer disease, highlighting how ...

Patients with breast cancer who participate in a tailored exercise program after surgery have better shoulder function after ...

A symposium held at the SLEEP 2024 Annual Meeting discussed updates in narcolepsy and idiopathic hypersomnia treatment, ...

Ravin Ratan, MD, MEd, MD Anderson, delves into how treatment paradigms and considerations differ between adult patients and ...

In the final overall survival analysis of the phase 3 CARES-310 trial, frontline camrelizumab plus rivoceranib continued to ...

Use of sodium oxybate and low-sodium oxybate led to meaningful improvements in patients with hypersomnia and narcolepsy ...

Panelists highlight the need for education and support to help clinicians appropriately prescribe prescription digital ...

Chief Health Equity Officer and Senior Vice President Aletha Maybank, MD, MPH, of the American Medical Association (AMA), ...

The coalition said, however, that patient-reported outcomes (PROs) in the myelodysplastic syndrome (MDS) space will be most ...